Cancer Research KI list of cancer research PIs across KI, B

Please find the blood cancer, nervous system cancer researchers at KI listed in the tables below.

Note that this is list is not complete and may still contain errors because the response rate on the conducted survey was below 100%. We would therefore like you to be in contact with us if you find that your name has been erroneously entered or if you would like to complete the current information in any way. Please send your update request to cancerresearchki@ki.se.

Blood cancer research

Blood
First Name Surname KI email Department Description Group website
Hassan Abolhassani hassan.abolhassani@ki.se Department of Biosciences and Nutrition (BioNut) I am working on cancers associated with inborn Errors of Immunity (IEI) as a heterogeneous group of 450 genetic disorders characterized by a defect in the function of immune system components. Our team aimed to identify the role of monogenic defects on oncologic hallmarks of IEI entities to dissect not only the impact of avoiding immune destruction, but also genome instability, and mutation, enabling replicative immortality, tumor-promoting inflammation, resisting cell death, sustaining proliferative signaling, evading growth suppressors, deregulating cellular energetics, inducing angiogenesis, and activating invasion and metastasis in these groups of patients. https://ki.se/en/bionut/we-study-human-b-cells-in-health-and-disease-qi…
Evren Alici evren.alici@ki.se Department of Medicine, Huddinge (MedH)
Svetlana Bajalica Lagercrantz svetlana.lagercrantz@ki.se Department of Oncology-Pathology (Onk-Pat)
Magnus Björkholm magnus.bjorkholm@ki.se magnus.bjorkholm@sll.se Department of Medicine, Solna (MedS) Biology of Hodgkin and related lymphomas. Epidemiology of hematological malignancies https://ki.se/meds/professor-magnus-bjorkholm
Petter Brodin petter.brodin@ki.se Department of Women's and Children's Health (KBH)
Yenan Bryceson yenan.bryceson@ki.se Department of Medicine, Huddinge (MedH) Our research group investigates the molecular regulation human cytotoxic lymphocyte differentiation and function. A major aim is to translate findings to improved cellular immunotherapy of cancer. https://ki.se/en/medh/yenan-bryceson-group
Mattias Carlsten mattias.carlsten@ki.se Department of Medicine, Huddinge (MedH)
Benedict Chambers benedict.chambers@ki.se Department of Medicine, Huddinge (MedH) My research examines the role of innate immune cells in cancer. https://ki.se/en/medh/benedict-chambers-group
Jonathan Coquet jonathan.coquet@ki.se Department of Microbiology, Tumor and Cell Biology (MTC) I study the role of the immune system in cancer elimination and growth.
Karin Ekström-Smedby karin.ekstrom.smedby@ki.se Department of Medicine, Solna (MedS) Risk, survival and survivorship of malignant lymphomas and other cancer forms
Martin Enge martin.enge@ki.se Department of Oncology-Pathology (Onk-Pat) We are developing novel single-cell multiomic methods and applying them to study gene regulation in patient samples from leukemias and solid cancers. https://ki.se/en/onkpat/martin-enges-group
Elisabeth Epstein elisabeth.epstein@ki.se Department of Clinical Science and Education, Södersjukhuset Multidisciplinary collaborations (with Scilife lab, KTH and other disciplines), spanning from cutting-edge translational research, innovative projects aiming to implement AI aim the diagnostic triage, and clinical ultrasound studies improving risk-prediction for every woman in order to optimize and individualize management.
Erin Gabriel Erin Gabriel Department of Medical Epidemiology and Biostatistics (MEB) I develop statistical methods that can be used in cancer research. https://staff.ki.se/orgid/5108361
Ingrid Glimelius ingrid.glimelius@ki.se Department of Medicine, Solna (MedS)
Moustapha Hassan moustapha.hassan@ki.se Department of Laboratory Medicine (LabMed) Our research aims mainly to 1. Individualize treatment during cancer therapy in order to improve the treatment efficacy and minimize the adverse effects.2. Develop preclinical models to investigate the mechanisms underlying the development of GvHD and cardiovascular toxicities in order to develop an appropriate prophylactic treatment. https://ki.se/en/labmed/experimental-cancer-medicine-ecm
Eva Hellström Lindberg eva.hellstrom-lindberg@ki.se Department of Medicine, Huddinge (MedH) improve cure rates and symptom-free survival for patients with myelodysplastic syndromes (MDS). https://ki.se/en/medh/myelodysplastic-syndromes
Jan-Inge Henter Jan-Inge.Henter@ki.se Department of Women's and Children's Health (KBH)
Mats Heyman mats.heyman@ki.se Department of Women's and Children's Health (KBH) Chief investigator for clinical trial in acute lymphoblastic leukaemia for children and young adults.Associated research into toxicity and clinical epidemiology of childhood cancer and cancer epidemiology of childhood cancer. https://ki.se/en/kbh/leukaemia-coagulation-clinical-trials-and-registry…
Petter Höglund petter.hoglund@ki.se Department of Medicine, Huddinge (MedH)
Sten Eirik Jacobsen sten.eirik.jacobsen@ki.se Department of Medicine, Huddinge (MedH) Cancer Stem Cells in Chronic Myeloid Malignancies https://ki.se/en/medh/sten-eirik-w-jacobsen-lab-hematopoietic-stem-cell… https://ki.se/en/labmed/research-group-helen-kaipe
Helen Kaipe helen.kaipe@ki.se Department of Laboratory Medicine (LabMed) https://ki.se/en/labmed/research-group-helen-kaipe
Olli-Pekka Kallioniemi olli.kallioniemi@ki.se Department of Oncology-Pathology (Onk-Pat)
Anna Karlsson anna.karlsson@ki.se Department of Laboratory Medicine (LabMed)
Mikael Karlsson mikael.karlsson@ki.se Department of Microbiology, Tumor and Cell Biology (MTC) Immunotherapy targeting the cancer stroma with a foucus on Macrophages and B cells. https://ki.se/en/mtc/mikael-karlsson-group
Klas Kärre klas.karre@ki.se Department of Microbiology, Tumor and Cell Biology (MTC)
Eva Kimby eva.kimby@ki.se Department of Medicine, Huddinge (MedH)
Soren Lehmann soren.lehmann@ki.se Department of Medicine, Huddinge (MedH)
Andreas Lennartsson andreas.lennartsson@ki.se Department of Biosciences and Nutrition (BioNut) We are working on epigenomic and transcriptomic regulation, and epigenetic treatment of acute leukemia in adults and children. https://ki.se/en/bionut/epigenetic-regulation-of-leukemia-and-normal-bl…
Stig Linder stig.linder@ki.se Department of Oncology-Pathology (Onk-Pat)
Anna Lindstrand anna.lindstrand@ki.se Department of Molecular Medicine and Surgery (MMK) Using zebrafish to develop combination therapies to overcome drug resistance in AML https://ki.se/mmk/sallsynta-diagnoser
Hans-Gustaf Ljunggren hans-gustaf.ljunggren@ki.se Department of Medicine, Huddinge (MedH) Cancer immunotherapy, in particular exploring the potential of using NK cells alone or in combination with other drugs in malignant diseases. Much of this is explored in Phase I or II clinical trials with extensive exploratory analysis of patient material following NK cell infusions. https://ki.se/en/medh/hans-gustaf-ljunggren-group
Per Ljungman per.ljungman@ki.se Department of Medicine, Huddinge (MedH) Viral infections after allogeneic stem cell transplantation with special focus on COVID-19 and CMV. Vaccination of stem cell transplant recipients
Vanessa Lundin vanessa.lundin@ki.se Department of Medicine, Huddinge (MedH) Translational hematology research focussing on in vitro modelling of human myeloid disease
Karl-Johan Malmberg kalle.malmberg@ki.se Department of Medicine, Huddinge (MedH)
Robert Månsson robert.mansson@ki.se Department of Laboratory Medicine (LabMed) The aim with our research is to understand the underlying genetic and gene regulatory aberrations in multiple myeloma to provide improved prognostics and understanding of disease development.
Mats Marshall Heyman mats.heyman@ki.se Department of Women's and Children's Health (KBH)
Sergio Martinez Hoyer sergio.martinez.hoyer@ki.se Department of Microbiology, Tumor and Cell Biology (MTC)
Maria Masucci maria.masucci@ki.se Department of Cell and Molecular Biology (CMB) mechanism of tumor virus immune regulation and oncogenesis
Jonas Mattsson jonas.mattsson@ki.se Department of Oncology-Pathology (Onk-Pat) Development of immunotherapy and CAR T-cell therapies in solid tumors with special focus on ovarian cancer https://ki.se/en/onkpat/jonas-mattssons-group
Håkan Mellstedt hakan.mellstedt@ki.se Department of Oncology-Pathology (Onk-Pat)
Jakob Michaelsson jakob.michaelsson@ki.se Department of Medicine, Huddinge (MedH)
Stephan Mielke stephan.mielke@ki.se Department of Laboratory Medicine (LabMed)
Anna Nilsson anna.nilsson.1@ki.se Department of Women's and Children's Health (KBH) Adaptive immunity in children with cancer. Effects of chemo on normal lymphocytes https://medarbetare.ki.se/orgid/5206307
Ann Nordgren ann.nordgren@ki.se Department of Molecular Medicine and Surgery (MMK)
Sam Okret sam.okret@ki.se Department of Biosciences and Nutrition (BioNut)
Anders Österborg Anders.osterborg@ki.se Department of Oncology-Pathology (Onk-Pat)
Caroline Palm Apergi caroline.palm.apergi@ki.se Department of Laboratory Medicine (LabMed) Our aim is to develop RNAi therapies into precision medicine against caner for treatment of both adult and pediatric cancers. Our goal is to develop a more selective and less toxic therapy against cancer and to identify new, potential biomarkers for cancer. https://ki.se/en/labmed/research-group-caroline-palm-apergi
Jan Palmblad jan.palmblad@ki.se Department of Medicine, Huddinge (MedH)
Qiang Pan Hammarström qiang.pan-hammarstrom@ki.se Department of Biosciences and Nutrition (BioNut) We study the mechanics involved in DNA repair and recombination during immunoglobulin gene diversification processes and their involvement in genome instability and cancer development. https://ki.se/en/bionut/we-study-human-b-cells-in-health-and-disease-qi…
Katja Pokrovskaja Tamm katja.pokrovskaja@ki.se Department of Oncology-Pathology (Onk-Pat) The aim is to find novel targets for anti-cancer therapy and develop drugs and drug combinations to overcome resistance and prevent relapse in childhood leukemia. Autophagy and STAT3 pathways are in focus of my research. https://ki.se/en/onkpat/katja-pokrovskaja-tamm-group
Hong Qian hong.qian@ki.se Department of Medicine, Huddinge (MedH)
Olle Ringdén olle.ringden@ki.se Department of Clinical Science, Intervention and Technology (ClinTec)
Richard Rosenquist Brandell richard.rosenquist@ki.se Department of Molecular Medicine and Surgery (MMK) Focusing on hematological malignancies and utilizing high-throughput sequencing and other innovative technologies, our research team has identified novel prognostic and predictive biomarkers that have refined disease classification and significantly improved patient risk-stratification and clinical decision-making.
Birgitta Sander birgitta.sander@ki.se Department of Laboratory Medicine (LabMed) Focussed on mantle cell lymphoma, new markers for prediction to therapy. https://ki.se/labmed/forskargrupp-birgitta-sander-birger-christensson
Dhifaf Sarhan dhifaf.sarhan@ki.se Department of Laboratory Medicine (LabMed) Cancer immunotherapy- Exploiting innate memory and immune sexual dimorphism in the tumor microenvironment.
Brinton Seashore-Ludlow brinton.seashore-ludlow@ki.se Department of Oncology-Pathology (Onk-Pat) We measure drug sensitivity and resistance profiles for individual patients with ovarian cancer.
Edvard Smith edvard.smith@ki.se Department of Laboratory Medicine (LabMed)
Anders Sönnerborg anders.sonnerborg@ki.se Department of Medicine, Huddinge (MedH)
Mattias Svensson mattias.svensson@ki.se Department of Medicine, Huddinge (MedH)
michael Uhlin michael.uhlin@ki.se Department of Clinical Science, Intervention and Technology (ClinTec) Investigate novel approaches to exploit the full immunotherapeutic capabilities of γδ T cells, both in AML patients undergoing HSCT and also in solid tumors.
Johanna Ungerstedt Johanna.Ungerstedt@ki.se Department of Medicine, Huddinge (MedH)
Trung Vu trungnghia.vu@ki.se Department of Medical Epidemiology and Biostatistics (MEB) Development and applications of statistical and computational methods for cancer genomics data
Björn E. E. Wahlin bjorn.wahlin@ki.se Department of Medicine, Huddinge (MedH)
Elisabete Weiderpass elisabete.weiderpass@ki.se Department of Medical Epidemiology and Biostatistics (MEB) www.iarc.fr https://www.iarc.who.int/office-of-the-director/
Lisa Westerberg lisa.westerberg@ki.se Department of Microbiology, Tumor and Cell Biology (MTC) Tumor Immunology and Cell biology https://ki.se/en/mtc/lisa-westerberg-group
Petter Woll petter.woll@ki.se Department of Medicine, Huddinge (MedH) Complementary studies on hematopoietic material from mouse and human bone marrow to characterise and target cells required and sufficient for the propagation of hematologic malignancies. https://ki.se/en/medh/petter-woll-group-leukemic-stem-cells
Anthony Wright anthony.wright@ki.se Department of Laboratory Medicine (LabMed) The focus is on how lymphoma/ leukaemia cells interact with healthy cells in microenvironments in order to increase their survival properties. We also study how these interactions are affected by a range of precision medicines, such as the BTK inhibitor Ibrutinib. https://ki.se/en/labmed/research-group-for-cancer-evolution
Giovanna Zinzalla giovanna.zinzalla@ki.se Department of Microbiology, Tumor and Cell Biology (MTC) I focus on two key molecular machineries: (1) MYC and other members of its Basic-Helix-Loop-Helix-Zipper (bHLHZip) network of transcription factors; and (2) the SWI/SNF (BAF) chromatin remodelling complexes.My research approaches encompass the use of chemistry, biochemistry, biophysics and structural biology with the ultimate goal of developing new anticancer agents. https://ki.se/en/mtc/giovanna-zinzalla-project

Brain and nervous system, cancer research

Brain and nervous system
First Name Surname KI email Department Description Group website
Igor Adameyko igor.adameyko@ki.se Department of Physiology and Pharmacology (Fyfa) We do study neuroblastoma origin and heterogeneity https://ki.se/en/fyfa/developmental-biology-and-regenerative-medicine
Lars Ährlund-Richter lars.ahrlund@ki.se Department of Women's and Children's Health (KBH)
Ernest Arenas ernest.arenas@ki.se Department of Medical Biochemistry and Biophysics (MBB)
Marie Arsenian-Henriksson marie.arsenian.henriksson@ki.se Department of Microbiology, Tumor and Cell Biology (MTC)
Jiri Bartek jiri.bartek.1@ki.se Department of Medical Biochemistry and Biophysics (MBB)
Klas Blomgren klas.blomgren@ki.se Department of Women's and Children's Health (KBH) Our research is focused on injury and repair in the juvenile brain and we have found that the young, still growing brain reacts very differently to injury compared with an adult brain.We focus primarily on the type of injuries inflicted by ionizing radiation to the young brain, as used in the treatment of malignant diseases. https://staff.ki.se/orgid/5206306
Gonçalo Castelo-Branco Goncalo.Castelo-Branco@ki.se Department of Medical Biochemistry and Biophysics (MBB) we investigate how oligodendrocyte precursor cells (OPCs) transition to glioma initiating cells (GICs) and whether OPCs can transition to immunocompetent states, as we previously observed in multiple sclerosis. https://ki.se/en/mbb/goncalo-castelo-branco-group
Mathilde Cheray mathilde.cheray@ki.se Institute of Environmental Medicine (IMM) Epigenetic reprogramming in brain tumors and their microenvironment https://ki.se/en/imm/unit-of-toxicology
Patrik Ernfors patrik.ernfors@ki.se Department of Medical Biochemistry and Biophysics (MBB)
Maria Feychting maria.feychting@ki.se Institute of Environmental Medicine (IMM) Epidemiological studies mainly on brain tumors and childhood cancers. https://ki.se/en/imm/unit-of-epidemiology
Christian Göritz christian.goeritz@ki.se Department of Cell and Molecular Biology (CMB) We study the tumor microenvironment (tumor stroma) in glioblastoma using mouse models and human tissue analysis. We investigate tumor stroma composition, origing and function. https://ki.se/en/cmb/christian-goritzs-group
Robert Harris robert.harris@ki.se Department of Clinical Neuroscience (CNS) Novel immunotherapies for glioblastoma multiforme. Focus on myeloid cells, as therapeutic agents, in studies of microglia depletion,and using nanoparticles to deliver siRNA https://ki.se/en/cns/robert-harris-research-group
Ola Hermanson ola.hermanson@ki.se Department of Neuroscience (NEURO) Using advanced molecular biology techniques and biomedical engineering to study and regulate stem cell-like cells in neural tumors and healthy brain to improve prognosis and treatment of pediatric and adult patients. https://ki.se/en/neuro/hermanson-laboratory
Johan Holmberg johan.holmberg@ki.se Department of Cell and Molecular Biology (CMB) Working on gene regulation and differentiation in neuroblastoma. https://ki.se/en/cmb/johan-holmbergs-group
John Inge Johnsen john.inge.johnsen@ki.se Department of Women's and Children's Health (KBH) Translational research on pediatric neural tumors https://ki.se/en/kbh/childhood-neural-tumor
Bertrand Joseph bertrand.joseph@ki.se Institute of Environmental Medicine (IMM) Myeloid cells contribution to brain tumours. https://ki.se/en/imm/bertrand-joseph-research-group
Kasper Karlsson kasper.karlsson@scilifelab.se Department of Oncology-Pathology (Onk-Pat) We develop new experimental and computational tools to predict drug response that take intra-tumoral heterogeneity into account. We also investigate ways to improve radiation based therapies for pediatric cancers. https://ki.se/en/onkpat/olli-kallioniemis-group
Per Kogner per.kogner@ki.se Department of Women's and Children's Health (KBH)
Jonas Muhr jonas.muhr@ki.se Department of Cell and Molecular Biology (CMB)
Monica Nister monica.nister@ki.se Department of Oncology-Pathology (Onk-Pat)
Shahrzad Shirazi Fard shahrzad.shirazi.fard@ki.se Department of Women's and Children's Health (KBH) My research set out to investigate consequences of tumour heterogeneity for the progression into refractory disease, with the objective to target residual disease and prevent metastasis
Catarina Träger catarina.trager@ki.se Department of Women's and Children's Health (KBH)
Malin Wickström malin.wickstrom@ki.se Department of Women's and Children's Health (KBH) Novel therapies for treatment of neuroblastoma. https://staff.ki.se/orgid/52063018
Peter Zaphiropoulos peter.zaphiropoulos@ki.se Department of Biosciences and Nutrition (BioNut)

Breast cancer research

Breast Cancer
First Name Surname KI email Department Description Group website
Göran Andersson goran.andersson@ki.se Department of Laboratory Medicine (LabMed)
Jonas Bergh jonas.bergh@ki.se Department of Oncology-Pathology (Onk-Pat)
Leander Blaas leander.blaas@ki.se Department of Biosciences and Nutrition (BioNut) We are studying breast development, breast cancer cells-of-origin, lineage plasticity,and tumor heterogeneity https://ki.se/en/bionut/breast-cancer-cells-of-origin-and-tumor-heterog…
Yvonne Brandberg yvonne.brandberg@ki.se Department of Oncology-Pathology (Onk-Pat) Psychosocial consequences of cancer disease and treatment, including health-related quality of life. Behavioral aspects of primary prevention. https://ki.se/en/onkpat/yvonne-brandbergs-group
Kamila Czene kamila.czene@ki.se Department of Medical Epidemiology and Biostatistics (MEB) I am breast cancer epidemiologists. Main focus of my research is genetic and mammographic factors of breast cancer prognosis https://staff.ki.se/people/kamcze
Jana de Boniface jana.de-boniface@ki.se Department of Molecular Medicine and Surgery (MMK) My cancer research focuses on de-escalation of axillary surgery, breast reconstruction and oncoplastic surgery, and effects of physical exercise on chemotherapy response. Survival analyses regarding different types of staging and breast surgery. https://staff.ki.se/orgid/5201118
Theodoros Foukakis theodoros.foukakis@ki.se Department of Oncology-Pathology (Onk-Pat) Drug and biomarker development in breast cancer with focus in multi-omics analyses and machine-learning using material from translational clinical trials
Jan Frisell jan.frisell@ki.se Department of Molecular Medicine and Surgery (MMK) Clinical Breast cancer research
Jonas Fuxe jonas.fuxe@ki.se Department of Laboratory Medicine (LabMed) We explore the interface between cancer and inflammation. In particular, we aim to elucidate how inflammatory signals contribute to cancer progression and metastasis by inducing epithelial-mesenchymal plasticity. https://ki.se/en/labmed/jonas-fuxe-group
Kristina Gemzell Danielsson kristina.gemzell@ki.se Department of Women's and Children's Health (KBH) We are focusing on understanding the cause, identifying biomarkers for risk prediction and early diagnosis and the development of possible prophylactic treatment witha focus on gynecological cancer (including breast cancer, and women with brca mutations and endometriosis) https://ki.se/en/kbh/reproductive-health
Per Hall per.hall@ki.se Department of Medical Epidemiology and Biostatistics (MEB) We aim to identify women at increased risk of breast cancer and provide them with means to lower their risk and to offer individualised breast cancer screening.
Johan Hartman johan.hartman@ki.se Department of Oncology-Pathology (Onk-Pat) Pathology; prediction of drug response in cancer patients. AI and molecular assays https://ki.se/en/onkpat/johan-hartmans-group
Keith Humphreys keith.humphreys@ki.se Department of Medical Epidemiology and Biostatistics (MEB) Developing statistical modelling approaches and applying them to large detailed cohorts, in order to understand aspects of tumour progression, heterogeneity and screening effectiveness.
Alicja Kuskowska-Wolk alicja.wolk@ki.se Institute of Environmental Medicine (IMM)
Urban Lendahl urban.lendahl@ki.se Department of Cell and Molecular Biology (CMB) We work on the role of dysregulated Notch signaling in cancer. https://ki.se/en/cmb/urban-lendahls-group
Barbro Linderholm barbro.linderholm@ki.se Department of Oncology-Pathology (Onk-Pat)
Linda Lindström Linda.Lindstrom@ki.se Department of Oncology-Pathology (Onk-Pat) Given the diversity of breast cancer and that the biological factors influencing the risk to die from the disease are not well understood, the Lindström research group’s main scientific interest is to identify the tumor and host characteristics needed to enable us to predict a patient’s long-term risk for fatal disease. We work interdisciplinary and currently focus our research into understanding the impact of intratumor heterogeneity, factors important for the long-term risk, endocrine therapy benefit, young versus older age at diagnosis, and benign breast diseases. https://ki.se/en/onkpat/linda-lindstroms-group
Mattias Rantalainen mattias.rantalainen@ki.se Department of Medical Epidemiology and Biostatistics (MEB) Medical research that is driven by statistical machine learning, artificial intelligence (AI) and large population representative data sets. Currently our research is centered on projects in the computational pathology domain. https://staff.ki.se/people/mattias-rantalainen
Charlotte Rolny charlotte.rolny@ki.se Department of Oncology-Pathology (Onk-Pat) We are studying the underlying mechanisms that regulate macrophages immunosuppressive and prometastatic functions. https://ki.se/en/onkpat/charlotte-rolnys-group
Kerstin Sandelin kerstin.sandelin@ki.se Department of Molecular Medicine and Surgery (MMK)
Staffan Strömblad staffan.stromblad@ki.se Department of Biosciences and Nutrition (BioNut) We study cell-matrix interactions and its down-stream mechanotransduction signaling and responses and how these affect key cellular processes of cancer cells. We use advanced light-microscopy and various in vitro and in vivo models and also analyze patient data and material. https://ki.se/en/bionut/cell-biology-of-cancer-staffan-stromblad-0
Nick Tobin nick.tobin@ki.se Department of Oncology-Pathology (Onk-Pat) Former wet lab biologist working as a bioinformatician for the last 10 years. My research interest lies in using large scale ‘omics data sets to better understand the biology of cancer and it’s potential clinical applications. We focus on the cell cycle and gene signatures in particular.
Rune Toftgård rune.toftgard@ki.se Department of Biosciences and Nutrition (BioNut)
Yvonne Wengström yvonne.wengstrom@ki.se Department of Neurobiology, Care Sciences and Society (NVS) Exercise oncology, symptom improvement, screening behaviour https://ki.se/nvs/wengstrom-group
Martin Wiedschwndter martin.widschwendter@ki.se Department of Women's and Children's Health (KBH)